The reiteration of a Market Outperform rating by JMP Securities, along with maintaining a high price target of $265, suggests a strong bullish outlook for Steris. This endorsement from a reputable analyst is likely to instill confidence in investors, potentially driving short-term positive momentum in the stock's price.